glp 1 receptor antagonist Complementary Yet Distinct Roles of GLP-1 Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction Glucagon Like Peptide 1 Receptor

Improvements in blood pressure within the 48-week treatment period resulted in the discontinuation of at least one antihypertensive medication in 41% of the participants in the combined 8 mg group and 30% of the participants in the 12 mg group

[DOI] [PubMed] [Google Scholar] 150.Drucker D.J

This is due to a response from the body to the stress of significant weight loss

Ali notes that fatigue or tiredness often occurs alongside weight loss, whether it is due to surgery, medication, or dietary changes

While co-receptor targeting, as seen with AMG133, has shown promising results in weight reduction, it remains unclear whether this is an additive or synergistic effect, or if the main mode of action behind appetite suppression is based on GLP-1 receptor activation (104)